ONECUT2 and cancer: One weakness of this initial approach, however, is that the majority of tumors in these datasets are of the more typical adenocarcinoma subtype, whereas CRPC tumors are of multiple subtypes (You et al., 2016), meaning that many of these tumors did not employ OC2 as a significant cancer driver.